ConductScience.org, home

Paper39744441

TBK1 inhibitor amlexanox exerts anti-cancer effects against endometrial cancer by regulating AKT/NF-κB signaling.

Shin J and 11 others. Int J Biol Sci, 2025. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. TBK1 inhibitor amlexanox exerts anti-cancer effects against endometrial cancer by regulating AKT/NF-κB signaling. Papers, record 39744441. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39744441

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
TBK1 inhibitor amlexanox exerts anti-cancer effects against endometrial cancer by regulating AKT/NF-κB signaling.
PubMed
Journal
Int J Biol Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
2.39, provisional
iCite
Revised in PubMed
2026-07-31
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shin JJiha
2Lim JJihoon
3Han DDaewon
4Lee SSolji
5Sung NSNak Song
6Kim JSJong-Seok
7Kim DKDo Kyung
8Lee HYHoi Young
9Lee SKSung Ki
10Shin JJongdae
11Kim JSJeong Sig
12Park HWHwan-Woo

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Endometrial NeoplasmsMajor topic
Protein Serine-Threonine KinasesMajor topic
NF-kappa BMajor topic
Signal TransductionMajor topic
Proto-Oncogene Proteins c-aktMajor topic
Cell ProliferationMajor topic
Female
Humans
Cell Line, Tumor
Animals
Mice
Aminopyridines
Mice, Nude
Cell Movement
Mice, Inbred BALB C

Source PubMed

Download CSV of topics

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120495575TGFbeta signalling: a complex web in cancer progression.Nat Rev Cancer2010https://conductscience.org/library/papers/20495575PubMed
225187272NF-κB, an active player in human cancers.Cancer Immunol Res2014https://conductscience.org/library/papers/25187272PubMed
333310066Tank Binding Kinase 1 modulates spindle assembly checkpoint components to regulate mitosis in breast and lung cancer cells.Biochim Biophys Acta Mol Cell Res2021https://conductscience.org/library/papers/33310066PubMed
428716898TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer.Cancer Res2017https://conductscience.org/library/papers/28716898PubMed
532444850Visualizing and interpreting cancer genomics data via the Xena platform.Nat Biotechnol2020https://conductscience.org/library/papers/32444850PubMed
629532994CiRS-7 targeting miR-7 modulates the progression of non-small cell lung cancer in a manner dependent on NF-κB signalling.J Cell Mol Med2018https://conductscience.org/library/papers/29532994PubMed
723836654Dissection of TBK1 signaling via phosphoproteomics in lung cancer cells.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/23836654PubMed
827287717IKBKE Is a Substrate of EGFR and a Therapeutic Target in Non-Small Cell Lung Cancer with Activating Mutations of EGFR.Cancer Res2016https://conductscience.org/library/papers/27287717PubMed
930808672AKT as a Therapeutic Target for Cancer.Cancer Res2019https://conductscience.org/library/papers/30808672PubMed
1030082428Carboxylic Acid Derivatives of Amlexanox Display Enhanced Potency toward TBK1 and IKKε and Reveal Mechanisms for Selective Inhibition.Mol Pharmacol2018https://conductscience.org/library/papers/30082428PubMed
1132630674The Specific IKKε/TBK1 Inhibitor Amlexanox Suppresses Human Melanoma by the Inhibition of Autophagy, NF-κB and MAP Kinase Pathways.Int J Mol Sci2020https://conductscience.org/library/papers/32630674PubMed
1228683283Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes.Cell Metab2017https://conductscience.org/library/papers/28683283PubMed
1329559975TANK-Binding Kinase 1-Dependent Responses in Health and Autoimmunity.Front Immunol2018https://conductscience.org/library/papers/29559975PubMed
1425581158A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesis.Nat Commun2015https://conductscience.org/library/papers/25581158PubMed
1521464307IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21464307PubMed
1636988258TBK1 promotes thyroid cancer progress by activating the PI3K/Akt/mTOR signaling pathway.Immun Inflamm Dis2023https://conductscience.org/library/papers/36988258PubMed
1721042276Emerging roles for the non-canonical IKKs in cancer.Oncogene2011https://conductscience.org/library/papers/21042276PubMed
1823082003The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer.Clin Cancer Res2012https://conductscience.org/library/papers/23082003PubMed
1934968491The potential value of amlexanox in the treatment of cancer: Molecular targets and therapeutic perspectives.Biochem Pharmacol2022https://conductscience.org/library/papers/34968491PubMed
2024449872Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancer.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/24449872PubMed

See all 48 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42793128Comprehensive Bioinformatic and miRNA-Driven Analysis of the Multimeric Canonical I Kappa B Kinase (IKK) Complex in Uterine Corpus Endometrial Carcinoma (UCEC).Biomolecules2026https://conductscience.org/library/papers/42793128PubMed
42682354Effects of TBK1 genetic polymorphisms and their interactions with hepatitis B virus mutations on the risk of hepatocellular carcinoma in Han Chinese population: a case-control study.Int J Surg2026https://conductscience.org/library/papers/42682354PubMed
42247008Spotlight on cGAS-STING: role in disease pathogenesis and therapeutic potential.Mol Biomed2026https://conductscience.org/library/papers/42247008PubMed
41488647TIR domain proteins: regulatory mechanisms in the tumor immune microenvironment, clinical translation strategies, and prospects for precision therapy applications.Front Immunol2025https://conductscience.org/library/papers/41488647PubMed
41416429Advancements on the synergistic application of oncolytic viruses and molecularly targeted therapies for the treatment of solid tumors (Review).Int J Oncol2026https://conductscience.org/library/papers/41416429PubMed
41318858Repurposing amlexanox as a topical anti-inflammatory and antioxidant intervention for diabetic foot ulcers: insights from in-silico and in-vivo studies.Inflammopharmacology2026https://conductscience.org/library/papers/41318858PubMed
40468448Matrix stiffness-induced IKBKE and MAPK8 signaling drives a phenotypic switch from DCIS to invasive breast cancer.Cell Commun Signal2025https://conductscience.org/library/papers/40468448PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
IRF33661PubTator's text mininghttps://conductscience.org/library/genes/3661NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
PTK2B2185PubTator's text mininghttps://conductscience.org/library/genes/2185NCBI Gene
TBK129110PubTator's text mininghttps://conductscience.org/library/genes/29110NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39744441

GET https://conductscience.org/api/papers/v1/39744441/references?page=2